Your browser doesn't support javascript.
loading
Dose adjustment of irinotecan based on UGT1A1 polymorphisms in patients with colorectal cancer.
Fujii, Hironori; Yamada, Yunami; Watanabe, Daichi; Matsuhashi, Nobuhisa; Takahashi, Takao; Yoshida, Kazuhiro; Suzuki, Akio.
Afiliação
  • Fujii H; Department of Pharmacy, Gifu University Hospital, Gifu, 501-1194, Japan. h_fujii@gifu-u.ac.jp.
  • Yamada Y; Department of Pharmacy, Gifu University Hospital, Gifu, 501-1194, Japan.
  • Watanabe D; Department of Pharmacy, Gifu University Hospital, Gifu, 501-1194, Japan.
  • Matsuhashi N; Department of Surgical Oncology, Gifu University Graduate School of Medicine, Gifu, 501-1193, Japan.
  • Takahashi T; Department of Surgical Oncology, Gifu University Graduate School of Medicine, Gifu, 501-1193, Japan.
  • Yoshida K; Department of Surgical Oncology, Gifu University Graduate School of Medicine, Gifu, 501-1193, Japan.
  • Suzuki A; Department of Pharmacy, Gifu University Hospital, Gifu, 501-1194, Japan.
Cancer Chemother Pharmacol ; 83(1): 123-129, 2019 01.
Article em En | MEDLINE | ID: mdl-30377777
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Polimorfismo Genético / Neoplasias Colorretais / Regulação Neoplásica da Expressão Gênica / Glucuronosiltransferase / Inibidores da Topoisomerase I / Irinotecano Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Polimorfismo Genético / Neoplasias Colorretais / Regulação Neoplásica da Expressão Gênica / Glucuronosiltransferase / Inibidores da Topoisomerase I / Irinotecano Idioma: En Ano de publicação: 2019 Tipo de documento: Article